Lateral femoral cutaneous neuritis, also named asmeralgia paresthetica or Roth syndrome, is markedby cutaneous pain or paresthesia such asformication or numbness in one or both thighs,which can be aggravated by prolon...Lateral femoral cutaneous neuritis, also named asmeralgia paresthetica or Roth syndrome, is markedby cutaneous pain or paresthesia such asformication or numbness in one or both thighs,which can be aggravated by prolonged standing orwalking; it is also characterized by hypoesthesia orskin sensibility without muscular atrophy ordyskinesia. Forty-three cases of lateral femoralcutaneous neuritis have been treated by pricking andcupping therapy since 1996. Now it was reported asfollows.展开更多
widely used development incidence of factors and Coronary stent implantation was considered as a way of coronary revascularization. It has been in the treatment of coronary heart disease, but restenosis has become the...widely used development incidence of factors and Coronary stent implantation was considered as a way of coronary revascularization. It has been in the treatment of coronary heart disease, but restenosis has become the main bottleneck to the of stent technique. Despite drug-eluting stents used widely, restenosis rate is still about 10%. The restenosis was associated with intervention injury, patient factors, genetic types, nerve endocrine so on Overview above aspects is expected to provide some ideas for restenosis prevention and treatment.展开更多
文摘Lateral femoral cutaneous neuritis, also named asmeralgia paresthetica or Roth syndrome, is markedby cutaneous pain or paresthesia such asformication or numbness in one or both thighs,which can be aggravated by prolonged standing orwalking; it is also characterized by hypoesthesia orskin sensibility without muscular atrophy ordyskinesia. Forty-three cases of lateral femoralcutaneous neuritis have been treated by pricking andcupping therapy since 1996. Now it was reported asfollows.
文摘widely used development incidence of factors and Coronary stent implantation was considered as a way of coronary revascularization. It has been in the treatment of coronary heart disease, but restenosis has become the main bottleneck to the of stent technique. Despite drug-eluting stents used widely, restenosis rate is still about 10%. The restenosis was associated with intervention injury, patient factors, genetic types, nerve endocrine so on Overview above aspects is expected to provide some ideas for restenosis prevention and treatment.
